ProText Mobility Inc (TXTM)

[stervc]

TXTM Patent Confirmation of its Phytofare®

Courtesy of OneBrokeMama, the links below indicates and confirms the patent for Phytofare® that now belongs to TXTM (Plandaí Biotechnology South Africa (SA)):
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=128356423

The patent for Phytofare® has a ”WO” Patent Number (WO2013122890A1) which means that it is... a patent number that indicates that the original patent application was filed under the Patent Cooperation Treaty, an international treaty that harmonizes the patent application process among member nations:
http://info.legalzoom.com/wo-patent-20217.html

The above is why finding the patent for Phytofare® was a little difficult to find, but now officially confirms its legitimacy on the next few levels within the medical world for licensing and distribution rights for TXTM (Plandaí Biotechnology SA).

https://patents.google.com/patent/WO2013122890A1/en?inventor=Roger+Duffield


Bioavailability of a substance relates to the amounts of the substance absorbed into the bloodstream and therefore to the availability of the substance for use by target tissues and cells in the body.

According to the Physician's Desk Reference, the absorption ratio of nutrients formulated into oral supplements as pills, tablets or soft gels varies between 1 -30%. Therefore, the real challenge is to overcome this problem of poor absorption and to efficiently transport and release the nutrients into the cells in order for the cells to do their healing work.

An objective of aspects of this process is to increase the bioavailability of phytonutrients from live plant materials.

v/r
Sterling